课题基金 / 基金详情

The Molecular Pathogenesis of Health Disparities in Inf*

The Molecular Pathogenesis of Health Disparities in Inf*
Inf* 健康差异的分子发病机制
批准号:
6776475
负责人:
EMMET HIRSCH
金额:
$30.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-24 至 2006-07-31

项目摘要

项目成果

EMMET HIRSCH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Racial and ethnic disparities in the incidence of preterm labor have been well documented, but the relative impact of genetic predisposition, as compared to environmental and behavioral factors is not known. The objective of this proposal is to test the hypothesis that differential gene expression contributes to disparity in infection-associated preterm labor. A second objective is the creation of two large and novel resources for studying preterm labor: (1) a database of candidate critical genes, and, (2) a human gene expression tissue bank. We suggest that elucidating the pathophysiology of preterm labor requires the power to perform analyses of the fetomaternal interactions required for parturition on a genomic scale. For practical and ethical reasons, a primary study of this type in humans would be severely limited. Therefore, in the first phase of this project, we will use a validated, tightly controlled murine model of infection-induced preterm labor to generate a comprehensive catalogue of gene expression over time in multiple tissues. Preterm pregnant mice will be randomized to treatment groups modeling one of clinical conditions: A. infection with labor; B. infection without labor; C. labor without infection; and D. no infection/no labor. RNA will then be collected from myometrium, ovaries, decidua, placentas and fetal membranes from each of the groups in a time series, and the relative expression of thousands of genes will be analyzed in these samples using DNA microarrays. A similarity metric and a clustering algorithm will be used to categorize individual genes by temporal expression patterns. A novel subtractive strategy will allow us to differentiate transcripts active specifically in infection-induced from those important for infection or labor alone. Inferences will be drawn regarding the involvement of genes not physic represented in the micro arrays by mapping into known functional pathways. The final result of this analysis will be a "short list" of candidate genes with potentially critical roles in infection-induced labor. In the second phase of the project, we analyze human tissues (myometrium, placenta, chorion, amnion, decidua, amniocytes and blood) collected from approximately 1360 patients presenting in term and preterm labor in a cross-sectional case-control study matching for race. Expression analysis in these tissues will be targeted to the human homologues of the enriched list of candidate critical genes identified in the mouse. Differential gene expression in pre term labor with or without infection and premature rupture membranes, as well as among different racial groups, will be characterized. A computational tool known as a support vector machine will be used to generate a rank order list predictive of preterm delivery, taking into account historical, clinical and laboratory variables. This tool will identify the subset(s) of genes most likely to form the genetic basis of preterm labor, and may provide a diagnostic molecular profiling instrument for predicting preterm delivery. The large databases generated in this study will be valuable to any researcher interested in parturition and will be made accessible on the Internet.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevention of Preterm Birth Using the Collectin Surfactant Protein A (SP-A)
Prevention of Preterm Birth Using the Collectin Surfactant Protein A (SP-A)
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: